A Phase II Trial of Combination of PD-1 Immune Checkpoint Inhibition with All-Lesion Stereotactic Radiation (SBRT) in Oligometastatic Renal Cell Carcinoma (Omrcc).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Immune Checkpoint Blockade,Metastatic Bladder Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined